Ameriprise’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.92M Sell
92,606
-8,210
-8% -$259K ﹤0.01% 2725
2025
Q1
$3.35M Sell
100,816
-2,985
-3% -$99.1K ﹤0.01% 2596
2024
Q4
$3.57M Buy
103,801
+18,730
+22% +$644K ﹤0.01% 2591
2024
Q3
$3.4M Sell
85,071
-2,974
-3% -$119K ﹤0.01% 2614
2024
Q2
$2.66M Sell
88,045
-7,105
-7% -$214K ﹤0.01% 2727
2024
Q1
$3.2M Sell
95,150
-3,916
-4% -$131K ﹤0.01% 2635
2023
Q4
$3.2M Sell
99,066
-11,321
-10% -$366K ﹤0.01% 2624
2023
Q3
$3.62M Buy
110,387
+1,665
+2% +$54.6K ﹤0.01% 2514
2023
Q2
$3.83M Sell
108,722
-1,470
-1% -$51.7K ﹤0.01% 2538
2023
Q1
$3.6M Sell
110,192
-54,190
-33% -$1.77M ﹤0.01% 2534
2022
Q4
$9.06M Buy
164,382
+26,779
+19% +$1.48M ﹤0.01% 1818
2022
Q3
$6.1M Buy
137,603
+42,478
+45% +$1.88M ﹤0.01% 2071
2022
Q2
$4.64M Buy
95,125
+700
+0.7% +$34.1K ﹤0.01% 2338
2022
Q1
$4.59M Sell
94,425
-8
-0% -$389 ﹤0.01% 2475
2021
Q4
$4.03M Buy
+94,433
New +$4.03M ﹤0.01% 2613